
Nathaniel Herzfeld
Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3743, 3749, 3762 |
| Total Applications | 626 |
| Issued Applications | 427 |
| Pending Applications | 1 |
| Abandoned Applications | 203 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18172702
[patent_doc_number] => 11572399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Long-acting GIP peptide analogues
[patent_app_type] => utility
[patent_app_number] => 16/617698
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 27019
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617698
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617698 | Long-acting GIP peptide analogues | May 30, 2018 | Issued |
Array
(
[id] => 13399895
[patent_doc_number] => 20180251490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/981503
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981503
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981503 | ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS | May 15, 2018 | Abandoned |
Array
(
[id] => 14158711
[patent_doc_number] => 20190106458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
[patent_app_type] => utility
[patent_app_number] => 15/978259
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978259 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | May 13, 2018 | Abandoned |
Array
(
[id] => 16125981
[patent_doc_number] => 10696732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Albumin variants
[patent_app_type] => utility
[patent_app_number] => 15/979319
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 26949
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15979319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/979319 | Albumin variants | May 13, 2018 | Issued |
Array
(
[id] => 15589651
[patent_doc_number] => 20200071360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/610171
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610171 | Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors | May 13, 2018 | Issued |
Array
(
[id] => 15882847
[patent_doc_number] => 10647755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Photoresponsive protein hydrogels and methods and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/974927
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 50
[patent_no_of_words] => 23140
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15974927
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/974927 | Photoresponsive protein hydrogels and methods and uses thereof | May 8, 2018 | Issued |
Array
(
[id] => 17783578
[patent_doc_number] => 11406683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Compounds and therapeutics uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/610741
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 2
[patent_no_of_words] => 14246
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610741 | Compounds and therapeutics uses thereof | May 3, 2018 | Issued |
Array
(
[id] => 15678461
[patent_doc_number] => 20200093894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => NOVEL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/610805
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610805 | NOVEL FORMULATIONS | May 2, 2018 | Abandoned |
Array
(
[id] => 15678461
[patent_doc_number] => 20200093894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => NOVEL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/610805
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610805 | NOVEL FORMULATIONS | May 2, 2018 | Abandoned |
Array
(
[id] => 16613635
[patent_doc_number] => 20210032288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PEPTIDES FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/609119
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609119 | Peptides for cancer treatment | Apr 26, 2018 | Issued |
Array
(
[id] => 18962922
[patent_doc_number] => 11896661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Influenza virus vaccine and method of making
[patent_app_type] => utility
[patent_app_number] => 16/608662
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 8250
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608662 | Influenza virus vaccine and method of making | Apr 26, 2018 | Issued |
Array
(
[id] => 13733099
[patent_doc_number] => 20180371017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => NOVEL ANALGESIC PHARMACEUTICAL FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/962200
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962200
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962200 | Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof | Apr 24, 2018 | Issued |
Array
(
[id] => 18517561
[patent_doc_number] => 11707431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Dental strips for the delivery of specifically targeted antimicrobial peptides
[patent_app_type] => utility
[patent_app_number] => 16/604135
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 20088
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 699
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604135 | Dental strips for the delivery of specifically targeted antimicrobial peptides | Apr 11, 2018 | Issued |
Array
(
[id] => 16762371
[patent_doc_number] => 20210107952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => BRASSICACEAE PROTEIN EXTRACT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/500494
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500494 | None | Apr 2, 2018 | Issued |
Array
(
[id] => 16824241
[patent_doc_number] => 20210139534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => METHOD FOR PURIFICATION OF ALBUMIN
[patent_app_type] => utility
[patent_app_number] => 16/492766
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492766 | Method for purification of albumin | Mar 15, 2018 | Issued |
Array
(
[id] => 15361051
[patent_doc_number] => 20200016290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => COMPOSITIONS AND METHODS INVOLVING PROBIOTIC MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/494421
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494421
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494421 | COMPOSITIONS AND METHODS INVOLVING PROBIOTIC MOLECULES | Mar 15, 2018 | Abandoned |
Array
(
[id] => 18604686
[patent_doc_number] => 11746136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Composition and methods for disruption of bacterial biofilms without accompanying inflammation
[patent_app_type] => utility
[patent_app_number] => 16/492582
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 28044
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492582 | Composition and methods for disruption of bacterial biofilms without accompanying inflammation | Mar 13, 2018 | Issued |
Array
(
[id] => 16806124
[patent_doc_number] => 20210128677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PEPTIDES FOR DRY EYE DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/492325
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492325
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492325 | Peptides for dry eye disease | Mar 5, 2018 | Issued |
Array
(
[id] => 16862797
[patent_doc_number] => 11021529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Antimicrobial constructs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/909006
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 41
[patent_no_of_words] => 26732
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909006
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/909006 | Antimicrobial constructs and uses thereof | Feb 28, 2018 | Issued |
Array
(
[id] => 15848237
[patent_doc_number] => 10639379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => High affinity CXCR4 selective binding conjugate and method for using the same
[patent_app_type] => utility
[patent_app_number] => 15/898434
[patent_app_country] => US
[patent_app_date] => 2018-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11842
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15898434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/898434 | High affinity CXCR4 selective binding conjugate and method for using the same | Feb 16, 2018 | Issued |